Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
Rapid and efficient quantification of intracellular M. tuberculosis growth is crucial for pursuing improved therapies against tuberculosis (TB). This protocol describes a broth-based colorimetric detection assay using an automated liquid culture system to quantify Mtb growth in macrophages treated with candidate host-directed therapies.
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), was the most significant infectious disease killer globally until the advent of COVID-19. Mtb has evolved to persist in its intracellular environment, evade host defenses, and has developed resistance to many anti-tubercular drugs. One approach to solving resistance is identifying existing approved drugs that will boost the host immune response to Mtb. These drugs could then be repurposed as adjunctive host-directed therapies (HDT) to shorten treatment time and help overcome antibiotic resistance.
Quantification of intracellular Mtb growth in macrophages is a crucial aspect of assessing potential HDT. The gold standard for measuring Mtb growth is counting colony-forming units (CFU) on agar plates. This is a slow, labor-intensive assay that does not lend itself to rapid screening of drugs. In this protocol, an automated, broth-based culture system, which is more commonly used to detect Mtb in clinical specimens, has been adapted for preclinical screening of host-directed therapies. The capacity of the liquid culture assay system to investigate intracellular Mtb growth in macrophages treated with HDT was evaluated. The HDTs tested for their ability to inhibit Mtb growth were all-trans Retinoic acid (AtRA), both in solution and encapsulated in poly(lactic-co-glycolic acid) (PLGA) microparticles and the combination of interferon-gamma and linezolid. The advantages of this automated liquid culture-based technique over the CFU method include simplicity of setup, less labor-intensive preparation, and faster time to results (5-12 days compared to 21 days or more for agar plates).
Mycobacterium tuberculosis (Mtb), the causative agent of TB, was the most significant infectious disease killer globally in 20191. To evade host defenses, Mtb subverts the mycobactericidal activity of innate immune cells such as macrophages and dendritic cells (DCs), allowing it to persist intracellularly and replicate2. The lack of an effective vaccine to prevent adult pulmonary TB and the increasing emergence of drug-resistant strains highlight the urgent need for new therapies.
Adjunctive host-directed therapies (HDT) could shorten treatment time and help overcome resistance3. Preclinical assessment of HDT candidates in vitro to determine mycobactericidal activity within macrophages often relies on the quantification of Mtb growth by colony-forming units (CFU) on solid agar plates. This is a slow, labor-intensive assay that does not lend itself to rapid screening of drugs. Commercially available automated, broth-based microbial detection systems are more commonly used in clinical microbiology laboratories for detection and drug susceptibility testing of Mtb and other mycobacterial species in clinical specimens4. These instruments measure growth indirectly based on the bacterial metabolic activity leading to physical changes in the culture media (change in CO2 or O2 levels or pressure) monitored over time5. The readout is time to positivity (TPP), which has previously been shown to correlate with Mtb CFU in sputum specimens of TB patients in response to treatment6,7 and in lysates of infected murine lung and spleen8. In addition, liquid culture detection systems have been used to measure the effect of conventional pathogen-directed therapies on the growth of mycobacteria in axenic culture and cultured macrophages9,10. The instrument has also been used to investigate the innate ability of dendritic cells and of alveolar macrophages to control intracellular growth of Mtb11,12. This experimental protocol demonstrates that a liquid culture diagnostic system can be adapted to perform preclinical screening of HDT for TB in cultured macrophages. Compared to CFU enumeration, the main advantage of this technique is that it considerably reduces the experimental labor and time required to quantify intracellular mycobacterial growth/survival. This technique relies on access to an automated culture instrument that can be used to assess intracellular mycobacterial survival in immune cells treated with a broad range of pharmacological reagents targeting cellular functions to boost host immunity.
Access restricted. Please log in or start a trial to view this content.
The experiments outlined in this protocol were carried out using the attenuated H37Ra strain of Mtb, which can be handled in a Containment Level 2 laboratory. All manipulations of live mycobacteria were carried out in Class II biological safety cabinet (BSC). Experimental procedures were designed to minimize the generation of aerosols. Eukaryotic cell culture (THP-1 cells) was also carried out in a Class II BSC. The laboratory carried out a risk assessment and ensured that all procedures were carried out in line with institutional and national biological safety regulations. The human monocytic THP-1 cell line was used to perform the method as described (step 1). Cells are differentiated into macrophages following stimulation with phorbol 12-myristate 13-acetate (PMA) before infection with mycobacteria.
1. Cell culture
2. Quantification of Mtb uptake
3. Harvesting samples for the liquid culture detection system
NOTE: On the day of infection, extracellular mycobacteria are removed by washing, and intracellular mycobacteria are harvested by lysis of one well of macrophages (3 h sample) to determine the initial amount phagocytosed as a baseline control for infection. At subsequent times both the medium, cell lysate, and washes are combined to measure total mycobacterial growth. Extracellular and intracellular growth can also be assessed separately if desired.
Access restricted. Please log in or start a trial to view this content.
The automated liquid culture instrument used in this study monitors CO2 levels every 10 min. A color change in the sensor at the bottom of the instrument bottle is measured colorimetrically and expressed as reflectance units. The instrument software then applies detection algorithms to calculate time to positivity (TTP), i.e., the number of days from inoculation until cultures are flagged as positive (Figure 1A). An inverse relationship between TTP and log10CFU (determi...
Access restricted. Please log in or start a trial to view this content.
The authors have used the liquid culture method described in this protocol to monitor Mtb growth in monocyte-derived macrophages and alveolar macrophages and THP-1 cells differentiated with PMA11,16,17. This technique can also be modified for use with non-adherent cells12. More recently, the instrument was also used in preclinical studies to evaluate inhaled all-trans retinoic acid (AtRA) as an HDT for TB...
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This work was funded by Science Foundation Ireland (SFI 08/RFP/BMT1689), the Health Research Board in Ireland [HRA-POR/2012/4 and HRA-POR-2015-1145] and Royal City of Dublin Hospital Trust.
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
IX51 Fluorescent Microscope | Olympus, Japan | N/A | AFB detection and imaging |
2 mL microtube, flat bottom, screw cap, sterile | Sarstedt, North Carolina, USA | 72.694.006 | Mtb infection of macropahges |
5 mL syringe, Luer lock | BD Biosciences, San Jose, CA, USA | SZR-150-031K | Mtb infection of macropahges/CFU |
50 mL tube, sterile | Sarstedt, North Carolina, USA | 62.547.254 | Mtb infection of macropahges |
all-trans-Retinoic Acid (ATRA) ≥98% (HPLC) | Sigma Aldrich, Missouri, USA | R2625 | Host directed therapy candidate |
BacT/ALERT 3D Microbial Detection System | Biomerieux ( Hampshire, UK) | 247001 | Broth-based colormetric detection system |
BACT/ALERT MP BACT/ALERT MP Nutrient Supplement | Biomerieux ( Hampshire, UK) | 414997 | Broth-based colormetric detection assay |
BACT/ALERT MP culture bottles | Biomerieux ( Hampshire, UK) | 419744 | Broth-based colormetric detection assay |
BD BBL Middlebrook ADC Enrichment, 20 mL | BD Biosciences, San Jose, CA, USA | M0553 | Mycobacterium liquid culture |
BD BBL Middlebrook OADC Enrichment, 20mL | BD Biosciences, San Jose, CA, USA | M0678 | Colony Forming Units |
Cell scraper, 25 cm | Sarstedt, North Carolina, USA | 83.1830 | Harvest of lmacrophage lysates |
Corning Syringe Filter, 0.2 µm | Corning Incorporated, Germany | 431219 | Sterilization of lysis buffer |
Cover glass (borosilicate), 24 x 50 mm, #1.5 thickness | VWR International Limited | 631 - 0147 | |
Cycloheximide, from microbial | Sigma Aldrich, Missouri, USA | C7698 | Colony Forming Units |
Dako Fluorescent Mounting Medium | Agilent Technologies Ireland Limited | S3023 | Antifade mounting medium |
Dulbecco’s Phosphate Buffered Saline | Sigma Aldrich, Missouri, USA | D8537 | Mtb infection of macropahges |
Fetal Bovine Serum, Gibco | Thermo Fisher, Massachusetts, USA | 10270106 | Macrophage cell culture |
Glycerol, Difco | BD Biosciences, San Jose, CA, USA | 228220 | Colony Forming Units |
Hoescht 33342 (bisBenzimide H 33342 trihydrochloride) | Sigma Aldrich, Missouri, USA | B2261 | Nuclear stain |
IFNγ, recombinant human | R&D Systems Inc, Minnesota, USA | 285-IF | Host directed therapy candidate |
Labtek 2-well chamber slide, sterile, Nunc | Thermo Fisher, Massachusetts, USA | TKT-210-150R | Mtb infection of macropahges |
L-Asparagine, anhydrous | Sigma Aldrich, Missouri, USA | A4159 | Colony Forming Units |
Linezolid | Sigma Aldrich, Missouri, USA | PZ0014 | Antibiotic |
Microlance Hypodermic Needle 25 G | BD Biosciences, San Jose, CA, USA | 300400 | Mtb infection of macropahges/CFU |
Middlebrook 7H10 Agar Base | BD Biosciences, San Jose, CA, USA | M0303 | Colony Forming Units |
Middlebrook 7H9 Broth Base | BD Biosciences, San Jose, CA, USA | M0178 | Mycobacterium liquid culture |
Modified Auramine O Stain and Decolourizer | Scientific Device Laboratory, IL, USA | 345-250 | AFB stain |
Paraformaldehyde | Sigma Aldrich, Missouri, USA | 158127 | Mtb infection of macropahges |
Petri dishes, 92 x 16mm (20/bag) | Sarstedt, North Carolina, USA | 82.1473.001 | Colony Forming Units |
Phorbol 12-myristate 13-acetate (PMA) | Sigma Aldrich, Missouri, USA | P8139 | Macrophage cell culture |
Polysorbate 80, Difco | BD Biosciences, San Jose, CA, USA | 231181 | Mycobacterium liquid culture |
RPMI-1640, Gibco | Thermo Fisher, Massachusetts, USA | 52400025 | Macrophage cell culture |
Sterile Cell Spreader, L-Shaped | Fisherbrand, Thermo Fisher, MA, USA | RB-44103 | Colony Forming Units |
T25 TC flask, angled neck, filter cap, sterile, Nunc | Thermo Fisher, Massachusetts, USA | 156367 | Mycobacterium liquid culture |
THP-1 cell line | ATCC, Virginia, USA | ATCC TIB-202 | Macrophage cell culture |
Access restricted. Please log in or start a trial to view this content.
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone